Wiley, Sara Leingang https://orcid.org/0000-0002-5474-3243
Razavi, Babak
Krishnamohan, Prashanth
Mlynash, Michael
Eyngorn, Irina
Meador, Kimford J.
Hirsch, Karen G.
Funding for this research was provided by:
American Heart Association (16MCPRP27750034)
National Heart, Lung, and Blood Institute (NIH NHLBI 1 R01 HL089116-01)
Article History
First Online: 23 June 2017
Compliance with Ethical Standards
:
: This study was funded through the National Institute of Health, National Heart Lung and Blood Institute (NIH NHLBI 1 R01 HL089116-01) and the American Heart Association (AHA 16MCPRP27750034). S.W. was supported through Amgen Scholars, Inc. in association with the Stanford School of Medicine Biosciences Summer Research Program. Sara Leingang Wiley was receiving funding through Semiconductor Research Corporation during the time of this study for research in physics curriculum including the investigation of neurodiagnostic modalities.Dr. Meador has received research support from the National Institutes of Health and UCB Pharma. The Epilepsy Study Consortium pays Dr. Meador’s university for his research consultant time related to Eisai, GW Pharmaceuticals, NeuroPace, Novartis, Supernus, Upsher-Smith Laboratories, UCB Pharma, and Vivus Pharmaceuticals.Dr. Hirsch has received research support from the National Institutes of Health and the American Heart Association.Dr. Razavi, Dr. Krishnamohan, Dr. Mlynash, and Dr. Eyngorn have no disclosures.